Published in
Cambridge University Press, Infection Control and Hospital Epidemiology, p. 1-4, 2022
DOI: 10.1017/ice.2022.14
Links
Tools
Duration of isolation and contagiousness in coronavirus disease 2019 (COVID-19) patients receiving tocilizumab and dexamethasone: A case series
Journal article published in 2022 by
Florence Côté 
,
Guy Boivin ,
Vilayvong Loungnarath,
Annie Ruest,
Julie Bestman-Smith,
Julie Carbonneau ,
Marie-Ève Hamelin ,
Marie-Claude Roy
,
Guy Boivin ,
Vilayvong Loungnarath,
Annie Ruest,
Julie Bestman-Smith,
Julie Carbonneau ,
Marie-Ève Hamelin ,
Marie-Claude Roy
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Abstract We describe 10 patients with severe coronavirus disease 2019 (COVID-19) who received tocilizumab and dexamethasone. We correlated isolation duration with cycle thresholds (Ct) values of nucleic acid amplification tests, clinical state and viral cultures. Isolation duration exceeded 21 days for 7 patients due to positive viral cultures or Ct values <30.